Moreover, highly expressed METTL3 can increase autophagy in NSCLC by upregulating autophagy-related proteins ATG5 and ATG7, and eventually lead to resistance to gefitinib and other EGFR TKI drugs. This evidence concerns the gene ATG5 and non-small cell lung carcinoma.